Being the most common musculoskeletal progressive condition, osteoarthritis is an
interesting target for research. It is estimated that the prevalence of knee osteoarthritis (OA) …

Osteoarthritis (OA) is one of the most debilitating diseases and is associated with a high
personal and socioeconomic burden. So far, there is no therapy available that effectively …

Osteoarthritis (OA) is a complex heterogeneous articular disease with multiple joint tissue
involvement of varying severity and no regulatory-agency-approved disease-modifying …

Osteoarthritis (OA) is a painful and debilitating condition of synovial joints without any
disease-modifying therapies [AM Valdes, TD Spector, Nat. Rev. Rheumatol. 7, 23–32 …

Background Modern pharmacological research found that the chemical components of
Curcuma longa L. are mainly curcumin and turmeric volatile oil. Several recent randomized …

Osteoarthritis (OA) is a leading cause of disability among older adults worldwide. Treatment
aims are to alleviate inflammatory pain and improve physical function through non …

Osteoarthritis (OA) is a chronic, progressive, multifactorial disease resulting in a progressive
loss of articular cartilage structure and function that is most common in middle-aged and …

The incidence of rheumatic diseases such as rheumatoid arthritis and osteoarthritis and
injuries to articular cartilage that lead to osteochondral defects is predicted to rise as a result …

Fibroblast activation protein (Fap) is a serine protease that degrades denatured type I
collagen, α2-antiplasmin and FGF21. Fap is highly expressed in bone marrow stromal cells …

The limited molecular classifications and disease signatures of osteoarthritis (OA) impede
the development of prediagnosis and targeted therapeutics for OA patients. To classify and …